'Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation' by Ali et al. - reassess the evidence, shall we?

Pharmacogenet Genomics. 2023 Jun 1;33(4):88-89. doi: 10.1097/FPC.0000000000000496. Epub 2023 Apr 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arabs / genetics
  • Cardiovascular Diseases*
  • Cytochrome P-450 CYP2C19 / genetics
  • Genotype
  • Hemorrhage / chemically induced
  • Humans
  • Percutaneous Coronary Intervention* / adverse effects
  • Platelet Aggregation Inhibitors / adverse effects
  • Stents / adverse effects
  • Treatment Outcome

Substances

  • Cytochrome P-450 CYP2C19
  • Platelet Aggregation Inhibitors
  • CYP2C19 protein, human